The substitute is the same crystals with a quarter to two-thirds of the sodium replaced by potassium chloride. Two levers pull at once: less sodium goes in, more potassium goes in, and both drop blood pressure 1. The catch: your kidneys clear extra potassium only when an adrenal hormone tells them to. Block that hormone with the wrong pill, or damage the kidneys, and potassium builds up in the blood instead. A day's use adds about a banana's worth, which a healthy person never notices.
One large, simple trial carries the case. Twenty-one thousand rural Chinese adults, all with high blood pressure or a prior stroke, got a 75/25 sodium-potassium shaker or their usual salt, assigned by village. Five years later: fewer strokes, fewer heart attacks, fewer deaths, systolic pressure about 3 mm Hg lower 1. A nursing-home trial saw cardiovascular events nearly halve 2, and a meta-analysis across thirty-two thousand people found the same mortality signal 3. Heart and kidney guidelines now name it as a tool 4.
First, find out which group you're in. The decision turns on your kidneys and your pills. Read the contraindications below; if none apply, the swap is nearly free and lifelong.
Nothing dramatic happens, and that is the point. The first two weeks taste like nothing changed. By week four a home cuff reads two to four points lower; by two months the full effect has landed, sometimes enough to defer a second pill 2. At five years the switched version of you carries a one-in-seven smaller chance of a stroke and a one-in-eight smaller chance of death 1. Stroke prevention is invisible until it isn't.
Thiazide and loop diuretics (hydrochlorothiazide, furosemide) lower potassium, so the swap is usually fine on those; the label or the pharmacist tells you which kind you take. In the US and UK only about a quarter of sodium comes from the home shaker, so expect less than the full trial effect if much of your food is restaurant or packaged.
The fine print — when to skip it, and what people get wrong
Keep regular salt, without doctor clearance, if any apply: stage 3b or worse kidney disease (eGFR under ~45) 4; a potassium-sparing diuretic — spironolactone, eplerenone, finerenone, amiloride, triamterene 5; both an ACE inhibitor and an ARB together; heart failure on a spironolactone-class drug; diabetic kidney disease; or drugs like trimethoprim, tacrolimus, or high-dose NSAIDs that nudge potassium up.
"It's just salt with less sodium." A teaspoon delivers roughly a small banana's potassium, closer to a low-dose supplement than to "lite" anything. "The trial proved it's safe." Only in screened people; kidney patients and those on potassium-sparing pills were never enrolled 1. "I'd feel it if potassium got too high." Mostly you won't — the first sign can be a fatal rhythm, which is why the check is a blood test.
- 1Neal et al. (2021). Effect of Salt Substitution on Cardiovascular Events and Death. New England Journal of Medicine. link
- 2Yuan et al. (2023). Salt substitution and salt-supply restriction for lowering blood pressure in elderly care facilities: a cluster-randomized trial. Nature Medicine. link
- 3Yin et al. (2022). Effects of salt substitutes on clinical outcomes: a systematic review and meta-analysis. Heart. link
- 4KDIGO (2024). KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. link
- 5Pitt et al. (1999). The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure (RALES). New England Journal of Medicine. link
დაკავშირებული სახელმძღვანელოში (7)
- — For someone with high blood pressure who cooks at home, swapping the shaker is one of the highest-leverage, lowest-effort moves there is.
- — If your kidneys are impaired, a potassium salt substitute can push potassium dangerously high — this is the one to avoid.
- — Knowing your eGFR matters before swapping to a potassium salt — low kidney function turns a heart-healthy swap risky.
- — Potassium salt substitutes are a concrete way to shift the sodium-potassium ratio in your favour.
- — If you change your salt to lower blood pressure, a week of home readings tells you whether it worked.
- — Potassium-based salt substitutes are one of the easiest ways to raise potassium intake, with the same kidney caveats.
- — Note that potassium salt substitutes usually aren't iodized — if you switch, mind where your iodine comes from.
Potassium-Blended Salt Substitutes
KCl-blended substitute runs $4–12/kg vs. $1–3/kg for table salt; typical 3–6 g/day use is pennies per day, well under $50/year. Trivial cost ladder.
Replace the table-salt shaker and read the label on the substitute brand — one-time setup. For readers on ACE/ARB, add a single serum-K check 2–4 weeks after switching, which is already part of normal monitoring (KDIGO 2024).
Multiple large RCTs (SSaSS n=20,995 with hard endpoints; DECIDE-Salt n=1,612; Bernabe-Ortiz Peru) plus Cochrane-level meta-analyses (Hernandez 2019, Yin 2022). Endorsed by AHA dietary guidance, 2025 ACC/AHA hypertension update, WHO sodium-reduction strategy. Aligned across cardiology and nephrology guidelines (KDIGO 2024) on both benefit and high-risk caveats (Neal 2021; Greer 2024).
SSaSS produced a 14% relative reduction in stroke (RR 0.86), 13% in MACE, and 12% in all-cause mortality over 4.7 years in 20,995 cluster-randomized adults — one of the largest mortality effects ever shown for a dietary intervention. Replicated by Yin meta-analysis (Neal 2021; Yin 2022). Discounted from 5 because the trial population (rural Chinese, high-Na baseline) overstates the effect in industrial diets.
Systolic BP falls 3–7 mm Hg within 2–8 weeks of switching, replicated across SSaSS (3.3 mm Hg, n=20,995), DECIDE-Salt (7.1 mm Hg), and Bernabe-Ortiz Peru. Felt as fewer headaches in SSaSS sub-analysis; clearer functional improvement in baseline hypertensives (Neal 2021; Yuan 2023; Hernandez 2019).